Intranasal COVID-19 Vaccine Developed by Indian Immunologicals and Griffith University
By Rediff Money Desk, New Delhi Aug 27, 2024 17:10
Indian Immunologicals Ltd and Griffith University have jointly developed a live-attenuated intranasal booster vaccine for COVID-19, aiming to enhance vaccination rates and combat the ongoing pandemic.
![Intranasal COVID-19 Vaccine Developed by Indian Immunologicals and Griffith University](https://im.rediff.com/money/2020/nov/26iil.jpg)
New Delhi, Aug 27 (PTI) Indian Immunologicals Ltd on Tuesday said it has jointly developed an intranasal vaccine for COVID-19.
The company said it has come up with a live-attenuated needle-free intra-nasal booster vaccine developed against SARS-CoV-2 using codon deoptimisation technology in collaboration with Griffith University, Australia.
"This accomplishment signifies a major step forward in our battle against COVID-19. The development of this vaccine not only highlights our dedication to innovation in public health but also demonstrates the company's capability in adopting novel technology," Indian Immunologicals Ltd (IIL) MD K Anand Kumar said in a statement.
By facilitating non-invasive immunisation, IIL aims to enhance vaccination rates, ultimately safeguarding more individuals and communities, he added.
As per the Hyderabad-based firm, COVID-19 is still a cause of around 1,700 deaths a week around the world.
The company said it has come up with a live-attenuated needle-free intra-nasal booster vaccine developed against SARS-CoV-2 using codon deoptimisation technology in collaboration with Griffith University, Australia.
"This accomplishment signifies a major step forward in our battle against COVID-19. The development of this vaccine not only highlights our dedication to innovation in public health but also demonstrates the company's capability in adopting novel technology," Indian Immunologicals Ltd (IIL) MD K Anand Kumar said in a statement.
By facilitating non-invasive immunisation, IIL aims to enhance vaccination rates, ultimately safeguarding more individuals and communities, he added.
As per the Hyderabad-based firm, COVID-19 is still a cause of around 1,700 deaths a week around the world.
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Rajnish Wellness
- 5.04 (+ 7.01)
- 42449137
- Genpharmasec Ltd
- 3.36 (+ 5.00)
- 28492007
- Filatex Fashions
- 1.16 ( -4.13)
- 25219108
- Vodafone Idea L
- 16.00 (+ 1.33)
- 24956839
- GTL Infrastructure
- 2.75 ( -1.43)
- 23046900
MORE NEWS
![GST Council to...](https://im.rediff.com/80-80/money/2020/jul/30gst.jpg)
GST Council to Discuss Rate Rationalization on...
India's GST Council will meet on September 9 to discuss rate rationalization and...
![V-Guard MD Fined...](https://im.rediff.com/80-80/money/2016/feb/10retire.jpg)
V-Guard MD Fined by RoC for Director...
The RoC has fined V-Guard Industries'' Managing Director M K Chittilappilly for...
![Coal Production...](https://im.rediff.com/80-80/money/2023/may/15coal.jpg)
Coal Production Rises 7% in April-August:...
India's coal production increased by 7.12% to 370.67 million tonnes between April and...